Trial Profile
Potency of antihypertensive therapy with Azilsartan on Walking Activity among Peripheral Artery Disease Patients With hypertention and Intermittent Claudication
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2015
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- 29 Sep 2015 Status changed from recruiting to discontinued, as reported by University Hospital Medical Information Network - Japan record.
- 27 Jun 2014 New trial record